Skip to main content
OpenTrials

Clinical trial condition

Thrombocytopenia

Explore clinical trials studying Thrombocytopenia. Study availability and eligibility vary by location and protocol.

409 public trials 118 recruiting studies
Refine in advanced search Browse all conditions

Thrombocytopenia trial results

Recruiting

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

NCT06533098

Conditions
Blood Platelet Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, +5 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC Davis School of Medicine Sacramento, California, United States
  • Childrens Hospital Colorado Aurora, Colorado, United States
  • Advocate Children's Hospital Park Ridge, Illinois, United States
View all 28 locations
View Trial Details
Recruiting

A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

NCT06449651

Conditions
Blood Platelet Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, +5 more
Locations
  • Universitair Ziekenhuis Leuven Leuven, Belgium
  • Instituto de Medicina Integral Professor Fernando Figueira Recife, Brazil
  • Hospital Das Clinicas Da Faculdade De Medicina Da USP São Paulo, Brazil
  • CHRU Lille Lille, France
View all 21 locations
View Trial Details
Recruiting

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

NCT07194850

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +22 more
Locations
  • Centre Hospitalier Universitaire de Bordeaux Groupe Hospitalier Pellegrin Hopital des Enfants Bordeaux, France
  • Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum (CVK) Berlin, Germany
  • Gaslini Children's Hospital Genoa, Italy
  • Fondazione IRCCS San Gerardo dei Tintori Monza, Italy
View all 22 locations
View Trial Details
Recruiting

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

NCT06721013

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Miami Hospital and Clinics Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
View all 43 locations
View Trial Details
Recruiting

Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease

NCT07549698

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +19 more
Locations
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Universitaetsklinikum Koeln Cologne, Germany
  • Medizinische Hochschule Hannover Hannover, Germany
View Trial Details
Recruiting

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

NCT07421167

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations
  • Stamford Hospital Stamford, Connecticut, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
  • DH Cancer Research Center LLC Margate, Florida, United States
  • Hope And Healing Care Hinsdale, Illinois, United States
View all 13 locations
View Trial Details
Recruiting

A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)

NCT07700238

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • MemorialCare Long Beach Medical Center Long Beach, California, United States
  • The Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
  • Hematology Oncology Associates of Fredericksburg Fredericksburg, Virginia, United States
View Trial Details
Recruiting

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

NCT07104565

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Palo Verde Cancer Specialists Palo Verde Hematology Oncology, Ltd Glendale Glendale, Arizona, United States
  • Usc Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Rocky Mountain Cancer Centers Lone Tree, Colorado, United States
  • Gnp Research Cooper City, Florida, United States
View all 39 locations
View Trial Details

Related conditions